Technical analysis of Inspire Medical Systems, Inc. (INSP): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Inspire Medical Systems, Inc. operates as a medical technology enterprise, concentrating on the development and commercialization of advanced, minimally intrusive therapies for patients diagnosed with obstructive sleep apnea (OSA) across both domestic U.S. and international markets.
Price Performance
| 1 month | +1.73% |
| 3 months | +36.31% |
| Year-to-date | -22.82% |
| 1 year | -1.25% |
| 3 years | -55.60% |
| 5 years | -73.90% |
52-Week Range
| 52-week High | $147.03 |
| 52-week Low | $38.91 |
| Avg Volume (90d) | 847K |
Technical Indicators
| SMA 50 | $68.45 |
| SMA 200 | $58.70 |
| Beta | 0.86 |
| 30-day Volatility (annualised) | 43.4% |
| Price vs SMA 50 | +4.0% |
| Price vs SMA 200 | +21.3% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-12 | $92.23 | |
| 2026-01 | $75.78 | -17.8% |
| 2026-02 | $64.51 | -14.9% |
| 2026-03 | $51.58 | -20.0% |
| 2026-04 | $56.14 | +8.8% |
| 2026-05 | $41.36 | -26.3% |
| 2026-06 | $44.61 | +7.9% |
| 2026-07 | $50.21 | +12.6% |
| 2026-08 | $62.99 | +25.5% |
| 2026-09 | $69.36 | +10.1% |
| 2026-10 | $71.18 | +2.6% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-11-02 | $0.09 | $204M |
| 2026-08-03 | $-0.24 | $195M |
| 2026-05-04 | $-0.28 | $200M |
| 2026-02-11 | $0.69 | $266M |
| 2025-11-03 | $-0.15 | $262M |
| 2025-08-04 | $0.22 | $214M |
| 2025-05-05 | $-0.23 | $228M |
Price
| Price | $68.10 (closing price, October 30, 2026) |
| Market Cap | $2.0B |
| Exchange | NYSE |
| Country | US |
Valuation Ratios
| P/E Ratio | 14.74 |
| Price / Book | 2.37 |
| EV / EBITDA | 23.58 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.04 |
| Current Ratio | 8.55 |
| Piotroski F-Score | 6 |
| Altman Z-Score | 14.49 |